 SAN DIEGO, CA ACCESSWIRE May 23, 2022 Dermata Therapeutics, Inc. NASDAQ:DRMA Dermata or the Company, a clinical-stage biotechnology company focusing on the treatment of medical and aesthetic skin conditions, today announced that Gerry Proehl, Dermatas Chairman, President, and Chief Executive Officer, will present a company overview at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022. 